Sarepta Therapeutics (SRPT) Director Buys 10K Shares
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Join SI Premium – FREE
After the close, Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Director Anthony Chase disclsoed the purchase of 10,000 shares on 6/14 at $38.50, bringing his stake to 28,244 shares.
Create E-mail Alert Related Categories
Insider TradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
